CLEC9A and neoplasm: (C) Neoantigens F-actin cytoskeleton on dying tumor cells binds DNGR-1 highly expressed on type1 conventional dendritic cells, which strengthens anti-cancer effects of CD8 + T cells through cross-presenting antigens with MHC-I molecules.